June 15, 2016
Salk scientists show how T-cell receptors reposition during an immune response, revealing more on how the immune system is regulated
Salk scientists show how T-cell receptors reposition during an immune response, revealing more on how the immune system is regulated
LA JOLLA—When the body is fighting an invading pathogen, white blood cells—including T cells—must respond. Now, Salk Institute researchers have imaged how vital receptors on the surface of T cells bundle together when activated.
This study, the first to visualize this process in lymph nodes, could help scientists better understand how to turn up or down the immune system’s activity to treat autoimmune diseases, infections or even cancer. The results were published the week of June 13, 2016 in Actas de la Academia Nacional de Ciencias.

Click-here para obtener una imagen en alta resolución.
Crédito: Instituto Salk
“We had seen these receptors cluster and reposition in cultured cells that were artificially stimulated in the lab, but we’ve never seen their natural arrangements in lymph nodes until now,” says senior author Björn Lillemeier, an associate professor in Salk’s Nomis Laboratories for Immunobiology and Microbial Pathogenesis, and the Centro Waitt de Biofotónica Avanzada.
T cells are activated when receptors embedded in their outer membrane bind to other immune cells that have digested an antigen, such as a virus, bacteria or cáncer cell. In turn, the activated T cells switch on cellular pathways that help the body both actively seek out and destroy the antigen and remember it for the future. In the past, by looking at T-cell receptors embedded in isolated cells under the microscope, researchers discovered that the receptors are arranged in clusters—called protein islands—that merge when the cells are activated.
Lillemeier wanted more detail on how the receptors are arranged in tissue and how that arrangement might change when the T cells are activated in living hosts. The team used a super-resolution microscope developed in the laboratory of co-senior author Hu Cang, assistant professor at Salk’s Waitt Advanced Biophotonics Center and holder of the Frederick B. Rentschler Developmental Chair. This microscopy approach, called light-sheet direct stochastic optical reconstruction microscopy (dSTORM), let the researchers watch T cell receptors in the membranes of T cells in mouse lymph nodes at a resolution of approximately 50 nanometers.
The new imagery confirmed the previous observation that protein islands of T-cell receptors merge into larger “microclusters” when T cells are activated. But it also showed that, before cells are activated, the protein islands are already arranged in groups—dubbed “territories” by Lillemeier’s team. “The pre-organization on the molecular level basically turns the T cell into a loaded gun,” says Lillemeier.

Click here for a high-resolution image
Crédito: Instituto Salk
The organization of surface receptors enables T cells to launch fast and effective immune response against antigens. Understanding how the molecular organization mediates the sensitivity of T cell responses could help researchers make the immune system more or less sensitive. In the case of autoimmune diseases, clinicians would like to turn down the immune system’s activity, while turning up the activity could help fight infections or cancers.
The research could also have implications for understanding other receptors in the body, which have a wide range of functions both within and outside the immune system. “We think that most receptors on the surfaces of cells are organized like this,” says Ying Hu, first author and postdoctoral researcher at the Salk Institute.
The work and the researchers involved were supported by grants from the Fundación NOMIS, la Waitt Foundation, the James B. Pendleton Charitable Trust, the Institutos Nacionales de Salud, la National Institute of Neurologic Disorders and Stroke, la Instituto Nacional del Cáncer and the California Institute for Regenerative Medicine.
DIARIO
Actas de la Academia Nacional de Ciencias
AUTORES
Ying S. Hu, Hu Cang, and Björn F. Lillemeier of the Salk Institute
Oficina de Comunicaciones
Tel.: (858) 453-4100
press@salk.edu
El Instituto Salk es un centro de investigación independiente y sin fines de lucro fundado en 1960 por Jonas Salk, creador de la primera vacuna segura y eficaz contra la poliomielitis. La misión del Instituto es impulsar una investigación fundamental, colaborativa y audaz que aborde los retos más acuciantes de la sociedad, entre ellos el cáncer, la enfermedad de Alzheimer y la vulnerabilidad agrícola. Esta ciencia fundamental sustenta todos los esfuerzos traslacionales, generando conocimientos que permiten el desarrollo de nuevos medicamentos e innovaciones en todo el mundo.